| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 04/16/2009 | CA2702171A1 Amide compound |
| 04/15/2009 | EP2048138A1 Salt or solvate of 5-methyl-2-(piperazin-1-yl)benzenesulfonic acid |
| 04/15/2009 | EP2048132A1 Tetrahydro-naphthalene and urea derivatives |
| 04/15/2009 | EP2046748A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 04/15/2009 | EP2046747A1 Substituted aminomethyl benzamide compounds |
| 04/15/2009 | EP2046722A2 Beta-3 receptor ligands and their use in therapy |
| 04/15/2009 | EP2046329A2 Soluble epoxide hydrolase inhibitors |
| 04/15/2009 | EP1945621B1 Process to prepare amino acid derivatives |
| 04/15/2009 | EP1703909B1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 04/15/2009 | CN101410376A Piperazinyl derivatives as modulators of chemokine receptor activity |
| 04/15/2009 | CN101410370A Selective hydroxamate based MMP inhibitors |
| 04/15/2009 | CN100478331C Inhibitors of cathepsin s |
| 04/15/2009 | CN100478325C Preparation method for aminophenol compound |
| 04/15/2009 | CN100477992C Substituted piperazine and piperidine calcium channel blockers |
| 04/14/2009 | US7517990 Method for deuteration of a heterocyclic ring |
| 04/14/2009 | US7517989 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/14/2009 | US7517910 Alkoxyphenylpropanoic acid derivatives |
| 04/14/2009 | US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 04/14/2009 | US7517885 e.g. 1-{c-4-[4-(2-isopropoxy-phenyl)-piperazin-1-yl]-; 467; 2.900;cyclohexyl}-r-3-(2-methoxy-phenyl)-urea; selective alpha 1a/ alpha 1d adrenoreceptor modulators; benign prostatic hypertrophy and lower urinary tract symptoms |
| 04/14/2009 | CA2385863C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 04/09/2009 | WO2009044707A1 Nitrotriazole derivative and method for producing compound using the same |
| 04/09/2009 | WO2009043117A1 Novel aryl potassium channel blockers and uses thereof |
| 04/09/2009 | WO2008122667A3 Ureylene derivatives |
| 04/09/2009 | WO2008073623A3 Soluble epoxide hydrolase inhibitors |
| 04/09/2009 | US20090093492 N-[4-chloro-2-hydroxy-3-(1-piperazinylsulfonyl)phenyl]-N'-(2-chloro-3-fluorophenyl) urea; treating a ELR chemokine mediated disease asthma, chronic obstructive pulmonary disease and adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, or ulcerative colitis, psoriasis |
| 04/09/2009 | US20090093484 Novel compounds, their preparation and use |
| 04/09/2009 | US20090093472 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
| 04/09/2009 | US20090093455 Quinolone analogs and methods related thereto |
| 04/09/2009 | CA2701579A1 Novel aryl potassium channel blockers and uses thereof |
| 04/08/2009 | EP2044044A2 Substituted phenyl acetic acids as dp-2 antagonists |
| 04/08/2009 | EP2044043A1 1- ý[- (2, 4-dimethylphenylsulfanyl) -phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
| 04/08/2009 | EP2043998A1 Method for producing an amine |
| 04/08/2009 | EP2043997A1 Method for producing an amine |
| 04/08/2009 | EP2043996A1 Method for producing an amine |
| 04/08/2009 | EP2043779A1 Method for producing an amine |
| 04/08/2009 | EP1606251B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 04/08/2009 | CN101405279A Process for preparing substituted aryl cycloalkanol derivatives |
| 04/08/2009 | CN101405254A Process for preparing an amine |
| 04/08/2009 | CN101402616A Method for producing rubber vulcanization agent 4,4'-disulfuration dimorpholine |
| 04/08/2009 | CN101402606A Nitrogen heterocyclic ring substituted arylpropenone compounds, preparation method and application thereof |
| 04/08/2009 | CN101402601A Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/08/2009 | CN100475799C Merocyanine derivatives for cosmetic use |
| 04/08/2009 | CN100475770C Method for the distillative separation of mixtures containing ethyleneamines |
| 04/07/2009 | US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 04/07/2009 | US7514475 Benzylamine analogues |
| 04/07/2009 | US7514431 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 04/07/2009 | CA2390116C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/07/2009 | CA2276278C Amine compounds, their production and use |
| 04/02/2009 | WO2009042970A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 04/02/2009 | WO2007115164A3 Amino acid surrogates for peptidic constructs |
| 04/02/2009 | WO2005057171A3 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
| 04/02/2009 | US20090088444 Substituted phenanthrene diketo acids and uses therefor |
| 04/02/2009 | CA2697580A1 Octahydropentalene compounds as chemokine receptor antagonists |
| 04/01/2009 | EP2042495A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/01/2009 | EP2042480A1 Aminoindan derivative or salt thereof |
| 04/01/2009 | EP2041105A2 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 04/01/2009 | EP2041104A1 Cinnamoyl-piperazine derivatives and their use as par- i antagonists |
| 04/01/2009 | EP2041093A1 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases |
| 04/01/2009 | EP2041088A1 Glycine transporter-1 inhibitors |
| 04/01/2009 | EP2041087A1 2 -oxybenzamide derivatives as parp inhibitors |
| 04/01/2009 | EP2040688A1 New cxcr2 inhibitors |
| 04/01/2009 | EP1082308B1 Heterocyclically substituted amides used as calpain inhibitors |
| 04/01/2009 | CN101400653A 11-beta HSD1 inhibitors |
| 04/01/2009 | CN101400407A Tropane prodrugs with central nervous system activity |
| 04/01/2009 | CN100473644C 9-substituted minocycline compounds |
| 03/31/2009 | US7511066 Antithrombotic aromatic ethers |
| 03/31/2009 | US7511047 Kinase inhibitors |
| 03/26/2009 | WO2009037394A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/26/2009 | US20090082562 Process for preparing an amine |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090082328 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
| 03/26/2009 | CA2693116A1 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/25/2009 | EP2039697A1 Fluoroboron compound, aminomethylating agent for aromatic ring comprising the compound, and process for production of compound having aminomethyl-aromatic ring using the aminomethylating agent |
| 03/25/2009 | EP2038269A1 Substituted benzamide modulators of the histamine h3 receptor |
| 03/25/2009 | EP2038253A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | CN101395129A Metal carboxylate salt nucleating or clarifying agent compounds and related polymer compositions and methods |
| 03/25/2009 | CN100471844C 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 03/25/2009 | CN100471843C Superhigh purity ionic liquid |
| 03/24/2009 | US7507823 Water is introduced to a stream of supercritical fluid which is then allowed to mix with a stream including a mixture including aripiprazole and a solvent; mixing results in the substantially simultaneous dispersion and extraction of the aripiprazole from the mixture by the supercritical fluid |
| 03/24/2009 | US7507816 Compounds for treatment of inflammation, antidepressants, nervous system disorders, cardiovascular disorders or analgesics from mannich reaction |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507545 Ion channel modulating activity method |
| 03/19/2009 | WO2009035307A2 Novel compounds, process for preparing the same, and composition comprising the same for inhibiting pain |
| 03/19/2009 | WO2009035020A1 Novel dihydronaphthalene compound and use thereof |
| 03/19/2009 | WO2009034390A1 Heterocyclic derivatives and their use in treating hepatitis c |
| 03/19/2009 | WO2009004485A3 Repaglinide substantially free of dimer impurity |
| 03/19/2009 | WO2008145075A3 Method for the preparation of lasofoxifene and crystalline intermediates used therein |
| 03/19/2009 | WO2008135886A3 Quinoline derivatives for use in the inhibition of the growth of tumour cells |
| 03/19/2009 | US20090076079 Deuterium-enriched methylphenidate |
| 03/19/2009 | US20090076005 Kinase inhibitor compounds |
| 03/19/2009 | US20090075993 N-[3-(1 -piperidinyl)propoxy]-pyridin-1-oxide-3-carboxamidine ; increasing vaso-relaxation of a vessel associated with endothelial cells |
| 03/19/2009 | US20090075989 Non-steroidal progesterone receptor modulators |
| 03/19/2009 | US20090075986 Anti-inflammatory medicaments |
| 03/19/2009 | US20090075975 Arylsulfonamides and uses related thereto |
| 03/19/2009 | US20090074746 Compounds to treat alzheimer's disease |
| 03/19/2009 | CA2697752A1 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 03/18/2009 | EP2036909A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof |
| 03/18/2009 | EP2036554A1 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment for diabetes mellitus |
| 03/18/2009 | EP2035465A2 Method for deprotecting aryl or alkyl sulfonamides of primary or secondary amines |